Company Encyclopedia
View More
name
AOHUA ENDOSCOPY
688212.SH
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general surgery, otolaryngology, orthopedics, urology, gynecology, gastroenterology, and emergency medicine. Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
880.38 B
688212.SHMarket value -Rank by Market Cap -/-

Financial Score

23/12/2025 Update
D
Health Care EquipmentIndustry
Industry Ranking55/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-5.51%D
    • Profit Margin-10.78%D
    • Gross Margin65.92%A
  • Growth ScoreD
    • Revenue YoY-10.46%D
    • Net Profit YoY-244.85%E
    • Total Assets YoY8.95%B
    • Net Assets YoY-9.82%D
  • Cash ScoreE
    • Cash Flow Margin-927.87%E
    • OCF YoY-10.46%D
  • Operating ScoreC
    • Turnover0.38C
  • Debt ScoreB
    • Gearing Ratio31.01%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    One of the actual controllers of AOHUA ENDOSCOPY, Gu Xiaozhou, plans to reduce his holdings by no more than 1.93%

    According to the Zhitong Finance APP, AOHUA ENDOSCOPY announced that Mr. Gu Xiaozhou, the company's controlling shareholder, one of the actual controllers, director, and general manager, plans to reduce his holdings by no more than 2.6 million shares through centralized bidding and block trading, with a total reduction ratio not exceeding 1.93% of the company's total share capital

    Zhitong·
    SH
    688212
    -3.21%
    Zhitong·
    SH
    688212
    -3.21%

    AOHUA ENDOSCOPY: Net loss of 40.7652 million yuan in the first half of 2025

    AOHUA ENDOSCOPY announced that its operating revenue in the first half of 2025 was 260 million yuan, a year-on-year decrease of 26.36%. The net loss attributable to shareholders of the listed company was 40.7652 million yuan, compared to a net profit of 5.6616 million yuan in the same period last year

    Zhitong·
    SH
    688212
    -3.21%
    Zhitong·
    SH
    688212
    -3.21%

    The medical equipment sector has declined in the short term, with MEDLANDER falling over 7%

    The medical equipment sector has seen a short-term decline, with MEDLANDER falling over 7%. Xiangyu Medical, AOHUA ENDOSCOPY, Lude Medical, VISHEE, and others have also followed suit

    Zhitong·
    SH
    688580
    -1.19%
    SH
    688273
    -0.50%
    SH
    688626
    -0.06%
    Zhitong·
    SH
    688580
    -1.19%
    SH
    688273
    -0.50%
    SH
    688626
    -0.06%

    Cathay Haitong: The medical equipment renewal policy continues to be implemented, and the procurement scale in 25H1 maintains rapid growth

    CITIC Securities released a research report indicating that the scale of medical equipment bidding and procurement will continue to grow in the first half of 2025, benefiting from the implementation of equipment renewal policies, which is expected to drive a long-term increase in medical equipment procurement levels. The industry rating is maintained at "Overweight," recommending companies such as Mindray, United Imaging Healthcare, SONOSCAPE, and AOHUA ENDOSCOPY. The notice issued by four ministries in 2024 aims for a growth of over 25% in equipment investment scale by 2027, which is expected to alleviate the financial pressure on hospitals and promote the recovery of equipment companies' performance

    Zhitong·
    SZ
    300633
    -1.35%
    SH
    688212
    -3.21%
    SZ
    300760
    -0.82%
    Zhitong·
    SZ
    300633
    -1.35%
    SH
    688212
    -3.21%
    SZ
    300760
    -0.82%

    AOHUA ENDOSCOPY: Junlian Xinkang and Gao Shan plan to reduce their holdings by a total of no more than 1.92% of the company's shares

    According to the Zhitong Finance APP, AOHUA ENDOSCOPY announced that Junlian Xinkang and Gao Shen plan to reduce their holdings in the company through centralized bidding and block trading, with a total reduction of no more than 2.5818 million shares, accounting for no more than 1.92% of the company's total share capital

    Zhitong·
    SH
    688212
    -3.21%
    Zhitong·
    SH
    688212
    -3.21%
    © 2025 Longbridge｜Disclaimer